Literature DB >> 10748179

Inhibition of glycogen-synthase kinase 3 stimulates glycogen synthase and glucose transport by distinct mechanisms in 3T3-L1 adipocytes.

S J Oreña1, A J Torchia, R S Garofalo.   

Abstract

The role of glycogen-synthase kinase 3 (GSK3) in insulin-stimulated glucose transport and glycogen synthase activation was investigated in 3T3-L1 adipocytes. GSK3 protein was clearly present in adipocytes and was found to be more abundant than in muscle and liver cell lines. The selective GSK3 inhibitor, LiCl, stimulated glucose transport and glycogen synthase activity (20 and 65%, respectively, of the maximal (1 microm) insulin response) and potentiated the responses to a submaximal concentration (1 nm) of insulin. LiCl- and insulin-stimulated glucose transport were abolished by the phosphatidylinositol 3-kinase (PI3-kinase) inhibitor, wortmannin; however, LiCl stimulation of glycogen synthase was not. In contrast to the rapid stimulation of glucose transport by insulin, transport stimulated by LiCl increased gradually over 3-5 h reaching 40% of the maximal insulin-stimulated level. Both LiCl- and insulin-stimulated glycogen synthase activity were maximal at 25 min. However, insulin-stimulated glycogen synthase activity returned to basal after 2 h, coincident with reactivation of GSK3. After a 2-h exposure to insulin, glycogen synthase was refractory to restimulation with insulin, indicating selective desensitization of this pathway. However, LiCl could partially stimulate glycogen synthase in desensitized cells. Furthermore, coincubation with LiCl during the 2 h exposure to insulin completely blocked desensitization of glycogen synthase activity. In summary, inhibition of GSK3 by LiCl: 1) stimulated glycogen synthase activity directly and independently of PI3-kinase, 2) stimulated glucose transport at a point upstream of PI3-kinase, 3) stimulated glycogen synthase activity in desensitized cells, and 4) prevented desensitization of glycogen synthase due to chronic insulin treatment. These data are consistent with GSK3 playing a central role in the regulation of glycogen synthase activity and a contributing factor in the regulation of glucose transport in 3T3-L1 adipocytes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10748179     DOI: 10.1074/jbc.M910002199

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  Expression profiling of the whole Arabidopsis shaggy-like kinase multigene family by real-time reverse transcriptase-polymerase chain reaction.

Authors:  Bénédicte Charrier; Anthony Champion; Yves Henry; Martin Kreis
Journal:  Plant Physiol       Date:  2002-10       Impact factor: 8.340

Review 2.  Targeting glycogen synthase kinase-3 (GSK-3) in the treatment of Type 2 diabetes.

Authors:  Katrina MacAulay; James R Woodgett
Journal:  Expert Opin Ther Targets       Date:  2008-10       Impact factor: 6.902

3.  Molecular and functional characterization of glycogen synthase in the porcine satellite cells under insulin treatment.

Authors:  Linjie Wang; Yuanzhu Xiong; Bo Zuo; Minggang Lei; Zhuqing Ren; Dequan Xu
Journal:  Mol Cell Biochem       Date:  2011-09-20       Impact factor: 3.396

4.  Biliverdin Reductase A Attenuates Hepatic Steatosis by Inhibition of Glycogen Synthase Kinase (GSK) 3β Phosphorylation of Serine 73 of Peroxisome Proliferator-activated Receptor (PPAR) α.

Authors:  Terry D Hinds; Katherine A Burns; Peter A Hosick; Lucien McBeth; Andrea Nestor-Kalinoski; Heather A Drummond; Abdulhadi A AlAmodi; Michael W Hankins; John P Vanden Heuvel; David E Stec
Journal:  J Biol Chem       Date:  2016-10-10       Impact factor: 5.157

5.  Glycogen serves as an energy source that maintains astrocyte cell proliferation in the neonatal telencephalon.

Authors:  Hitoshi Gotoh; Tadashi Nomura; Katsuhiko Ono
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

6.  Regulation of proteolytic cleavage of retinoid X receptor-α by GSK-3β.

Authors:  Weiwei Gao; Jie Liu; Mengjie Hu; Mingfeng Huang; Sisi Cai; Zhiping Zeng; Bingzhen Lin; Xihua Cao; Jiebo Chen; Jin-zhang Zeng; Hu Zhou; Xiao-kun Zhang
Journal:  Carcinogenesis       Date:  2013-02-06       Impact factor: 4.944

Review 7.  Physiological roles of glycogen synthase kinase-3: potential as a therapeutic target for diabetes and other disorders.

Authors:  J R Woodgett
Journal:  Curr Drug Targets Immune Endocr Metabol Disord       Date:  2003-12

8.  LRP1 controls intracellular cholesterol storage and fatty acid synthesis through modulation of Wnt signaling.

Authors:  Jérome Terrand; Véronique Bruban; Li Zhou; Wanfeng Gong; Zeina El Asmar; Petra May; Kai Zurhove; Philipp Haffner; Claude Philippe; Estelle Woldt; Rachel L Matz; Céline Gracia; Daniel Metzger; Johan Auwerx; Joachim Herz; Philippe Boucher
Journal:  J Biol Chem       Date:  2008-11-06       Impact factor: 5.157

9.  Shilianhua extract inhibits GSK-3beta and promotes glucose metabolism.

Authors:  Jun Yin; Aamir Zuberi; Zhanguo Gao; Dong Liu; Zhijun Liu; Jianping Ye
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-04-07       Impact factor: 4.310

10.  Tissue-specific role of glycogen synthase kinase 3beta in glucose homeostasis and insulin action.

Authors:  Satish Patel; Bradley W Doble; Katrina MacAulay; Elaine M Sinclair; Daniel J Drucker; James R Woodgett
Journal:  Mol Cell Biol       Date:  2008-08-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.